Acute Chest Syndrome in Children with Sickle Cell Disease
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Acute chest syndrome (ACS) is a frequent cause of acute lung disease in children with sickle cell disease (SCD). Patients may present with ACS or may develop this complication during the course of a hospitalization for acute vaso-occlusive crises (VOC). ACS is associated with prolonged hospitalization, increased risk of respiratory failure, and the potential for developing chronic lung disease. ACS in SCD is defined as the presence of fever and/or new respiratory symptoms accompanied by the presence of a new pulmonary infiltrate on chest X-ray. The spectrum of clinical manifestations can range from mild respiratory illness to acute respiratory distress syndrome. The presence of severe hypoxemia is a useful predictor of severity and outcome. The etiology of ACS is often multifactorial. One of the proposed mechanisms involves increased adhesion of sickle red cells to pulmonary microvasculature in the presence of hypoxia. Other commonly associated etiologies include infection, pulmonary fat embolism, and infarction. Infection is a common cause in children, whereas adults usually present with pain crises. Several risk factors have been identified in children to be associated with increased incidence of ACS. These include younger age, severe SCD genotypes (SS or Sβ0 thalassemia), lower fetal hemoglobin concentrations, higher steady-state hemoglobin levels, higher steady-state white blood cell counts, history of asthma, and tobacco smoke exposure. Opiate overdose and resulting hypoventilation can also trigger ACS. Prompt diagnosis and management with intravenous fluids, analgesics, aggressive incentive spirometry, supplemental oxygen or respiratory support, antibiotics, and transfusion therapy, are key to the prevention of clinical deterioration. Bronchodilators should be considered if there is history of asthma or in the presence of acute bronchospasm. Treatment with hydroxyurea should be considered for prevention of recurrent episodes. This review evaluates the etiology, pathophysiology, risk factors, clinical presentation of ACS, and preventive and treatment strategies for effective management of ACS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.10517 · Cited by 1,599
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422502 · Cited by 1,234 · cited 10×
“It can also progress rapidly from mild hypoxemia to acute respiratory failure within 24 h of onset of respiratory symptoms, which in itself constitutes a distinct clinical phenotype of ACS.(6,30,32) This form of rapidly progressive ACS is seen more commonly in adults as compared with children with SCD, and is frequent…”
BackgroundMethodInfluentialAcute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573 · cited 3×
“It can also progress rapidly from mild hypoxemia to acute respiratory failure within 24 h of onset of respiratory symptoms, which in itself constitutes a distinct clinical phenotype of ACS.(6,30,32) This form of rapidly progressive ACS is seen more commonly in adults as compared with children with SCD, and is frequent…”
BackgroundExtracellular hemin crisis triggers acute chest syndrome in sickle mice
Ghosh, S., Adisa, O. A., Chappa, P., Tan, F., Jackson, K. A., Archer, D. R., & Ofori-Acquah, S. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64578 · Cited by 282
Incentive Spirometry to Prevent Acute Pulmonary Complications in Sickle Cell Diseases
Bellet, P. S., Kalinyak, K. A., Shukla, R., Gelfand, M. J., & Rucknagel, D. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331104 · Cited by 278 · cited 2×
“The use of aggressive incentive spirometry while awake to prevent atelectasis is an important aspect of management.(78,79) Alternatively, the use of mechanical chest physiotherapy maneuvers, such as positive expiratory pressure devices, may be considered in younger children who may not be able to coordinate incentive…”
MethodPulmonary Artery Thrombosis during Acute Chest Syndrome in Sickle Cell Disease
Dessap, A. M., Deux, J.-F., Abidi, N., Lavenu-Bombled, C., Melica, G., Renaud, B., Godeau, B., Adnot, S., Brochard, L., Brun-Buisson, C., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0783oc · Cited by 144 · cited 1×
“ACS episodes without associated peripheral thrombosis, possibly suggestive of in situ thrombosis leading to infarction.(18) Furthermore, there is a high prevalence of pulmonary embolism in patients with SCD associated with thrombosis in the distal venous circulation.”
BackgroundAirway hyperreactivity in children with sickle cell disease
Leong, M. A., Dampier, C., Varlotta, L., & Allen, J. L. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70166-5 · Cited by 140
Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease
Styles, L. A., Aarsman, A. J., Vichinsky, E. P., & Kuypers, F. A. (2000) · Blood · doi:10.1182/blood.v96.9.3276 · Cited by 105
Adisa, O. A., Hu, Y., Ghosh, S., Aryee, D., Osunkwo, I., & Ofori‐Acquah, S. F. (2013) · British Journal of Haematology · doi:10.1111/bjh.12445 · Cited by 88 · cited 8×
“This article reviews the etiology, pathophysiology, risk factors, clinical features, diagnosis, treat- ment, and preventive strategies of ACS in pediatric patients with SCD. Etiology and Pathophysiology ACS is a form of acute lung injury in SCD.”
ResultInfluentialThe intersection between asthma and acute chest syndrome in children with sickle-cell anaemia
DeBaun, M. R., & Strunk, R. C. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00145-8 · Cited by 82
Chaturvedi, S., Ghafuri, D. L., Glassberg, J., Kassim, A. A., Rodeghier, M., & DeBaun, M. R. (2016) · American Journal of Hematology · doi:10.1002/ajh.24539 · Cited by 60 · cited 2×
“The etiology and underlying pathophysiological mechanisms of this subgroup of ACS are unclear, but shares resemblance with other thrombotic microangiopathic syndromes.(32,34,35) The presentation, causal mechanisms, and natural course of ACS differ considerably with age.”
BackgroundThe Role of RIB Infarcts in the Acute Chest Syndrome of Sickle Cell Diseases
Rucknagel, D. L. (2001) · Pediatric Pathology & Molecular Medicine · doi:10.1080/15513810109168607 · Cited by 32 · cited 1×
“Pain arising from thoracic bone infarction (ribs, sternum, and thoracic spine) leads to alveolar hypoventilation(86) and is highly correlated with development of ACS.(87) The goal of effective pain management should be to achieve a balance between analgesia to reduce respiratory splinting and hypoventilation, while av…”
Background
Cited by
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia
Vichinsky, E., Williams, R., Das, M., Earles, A., Lewis, N., Adler, A., & McQuitty, J. (1994) · Blood · doi:10.1182/blood.v83.11.3107.3107 · Cited by 261
Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease
Styles, L. A., Aarsman, A. J., Vichinsky, E. P., & Kuypers, F. A. (2000) · Blood · doi:10.1182/blood.v96.9.3276 · Cited by 105
Metadata
- Authors
- Jain, S., Bakshi, N., & Krishnamurti, L.
- Venue
- Pediatric Allergy, Immunology, and Pulmonology
- Publisher
- SAGE Publications
- Published
- 2017-12
- Volume
- 30
- Issue
- 4
- Pages
- 191-201
- ISSN
- 2151-321X (ISSN-L)
- 2151-3228
- OpenAlex
- W2775071287
- Cited by
- 169
- References
- 15
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.